Global Perspectives and Clinical Resources on BTK Inhibitor Therapy for Patients With CLL

In this program focused on global perspectives, get up to date on key topics in the use of BTK inhibitors for treating CLL with an expert-authored interactive text module and short commentary, downloadable slides, and Interactive Decision Support Tools for CLL and BTK inhibitor AE management.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca